Pharmacist prescribing activities - An electronic survey on the opinions of Australian Pharmacists

Journal of Pharmacy Practice and Research

Volumn 36, Issue 3, 2006, Pages 199-203

  Kay, Olivia C ^a,c   Bajorek, Beata V ^b   Brien, Jo Anne E ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AUSTRALIA; AWARENESS; CLINICAL DECISION MAKING; CLINICAL PHARMACY; CLINICAL PRACTICE; CONTROLLED STUDY; E-MAIL; FEMALE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL SOCIETY; PHARMACIST; PRESCRIPTION; REVIEW;

EID: 33749983620     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2006.tb00607.x     Document Type: Review

References (55)

1. Carmichael JM, O'Connell MB, Devine B, Kelly HW, Ereshefsky L, Linn WD, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy 1997; 17: 1050-61.
2. Galt KA. The key to pharmacist prescribing: collaboration. Am J Health Syst Pharm 1995; 52: 1696-9.
3. Department of Health. Review of prescribing, supply and administration of medicines (Crown Report). London: Department of Health; 1999.
4. Anon. Pharmacist independent prescribing given the go-ahead. Pharm J 2005; 275: 621.
5. Anon. Consultation on independent prescribing starts. Pharm J 2005; 274: 257.
6. Department of Health. Improving patients' access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England. London: Department of Health; 2006.
7. Pearson G, Yuksel N, Card D, Chin T, Gray M, Hawbold J, et al. An information paper on pharmacist prescribing within a health care facility. Can J Hosp Pharm 2002; 55: 56-62.
8. Carver LK. Pharmacist clinicians-addressing 21st century health care needs. Pharm Pract Manage Q 1995; 15: 1-8.
9. Wong EY. Management of acute and chronic pain. Hosp Pharm 1998; 33: 1044-56.
10. Barry CP, Fuller TS. Collaborative drug therapy management: home and hospice care. Hosp Pharm 1998; 33: 797-799, 818.
11. Cahill RJ. Pharmacist prescribing in a community hospital. Pharm Pract Manage Q 1995; 15: 43-5.
12. Berggren P, Matsuoka R. Pharmacy protocol for adjusting patient-controlled analgesia. Hosp Pharm 1990; 25: 928-9, 932.
13. Menard PJ, Krishner BS, Kloth DD, Pyka RS, Hill LR, Venkataraman K. Management of the hypertensive patient by the pharmacist prescribes Hosp Pharm 1986; 21: 20-33.
14. McGhan WF, Stimmel GL, Hall TG, Gilman TM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care 1983; 21: 435-44.
15. Hawkins DW, Fiedler FP, Herschel DL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979; 36: 1321-5.
16. Cooke CE, Mullins CD. Evaluating the economic impact of a pharmacist-managed hypertension program [abstract]. Pharmacotherapy 1999; 19: 523-4.
17. Reinders TP, Rush DR, Baumgartner RP, Graham AW. Pharmacist's role in management of hypertensive patients in an ambulatory care clinic. Am J Hosp Pharm 1975; 32: 590-4.
18. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002; 22: 1294-300.
19. Anaya JP. Outcomes evaluation of pharmacist-managed diabetes mellitus patients under a collaborative drug therapy agreement [abstract]. Pharmacotherapy 2000; 20: 1266.
20. Furmaga EM. Pharmacist management of a hyperlipidemia clinic. Am J Hosp Pharm 1993; 50: 91-5.
21. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm 1992; 49: 387-94.
22. Radley AS, Hall J, Farrow M, Carey PJ. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol 1995; 48: 545-7.
23. Cohen IA, Hutchinson TA, Kirking DM, Shue ME. Evaluation of a pharmacist-managed anticoagulant clinic. J Clin Hosp Pharm 1985; 10: 167-75.
24. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care-anticoagulant control, patient outcomes, and health care costs. Arch Intern Med 1998; 158: 1641-7.
25. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulant clinic. Drug Intell Clin Pharm 1985; 9: 575-80.
26. Garabedian-Ruffalo SM, Gray DR, Saw MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985; 42: 304-8.
27. Chenella FC, Klotz TA, Gill MA, Kern JW, McGhan WF, Paulson YJ, et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. Am J Hosp Pharm 1983; 40: 1642-5.
28. Martin JE, Begg E. Evaluation of a pharmacist-managed anticoagulation clinic within an accredited ambulatory care pharmacist: pilot study [abstract]. Can J Hosp Pharm 1998; 51: 297.
29. Wong EY, Barry CP. Collaborative drug therapy management: anticoagulation therapy. Hosp Pharm 1998; 33: 1166-1171, 1219.
30. Radley AS, Hall J. The establishment and evaluation of a pharmacist-developed anticoagulant clinic. Pharm J 1994; 252: 91-2.
31. Macgregor SH, Hamley JG, Dunbar JA, Dodd TRP, Cromarty JA. Evaluation of a primary care anticoagulant clinic managed by a pharmacist. BMJ 1996; 312: 560.
32. Norton JL. Prescribing warfarin at Overlake hospital medical center. Pharm Pract Manage Q 1995; 15: 17-23.
33. Horne AL, Dapolite LA. Protocol for pharmacist management of antineoplastic drug-induced adverse effects in outpatients. Am J Health Syst Pharm 1997; 54: 680-3.
34. Martin JK. Pharmacist prescriptive authority in the ambulatory oncology clinic. Pharm Pract Manage Q 1995; 15: 34-42.
35. Bosnic-Anticevich S, Armour C, Krass I, Saini B. Pharmacy asthma action plan. Canberra: The Pharmacy Guild of Australia; 2003.
36. Krass I, Taylor S, McInnman A, Armour C. Community pharmacists' role in the continuity of care in type 2 diabetes: an evaluation of a model. Canberra: The Pharmacy Guild of Australia; 2004.
37. Hughes J. Improving patient compliance and clinical outcomes through community pharmacist managed care. Canberra: The Pharmacy Guild of Australia; 2003.
38. McLachlan A, Spindler M, Fois R, Krass I, Chen T, Bajorek B. A community pharmacy based anticoagulant management service. Canberra: The Pharmacy Guild of Australia; 2002.
39. Jackson S, Peterson G, Vial J. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation. Ann Pharmacother 2004; 38: 1794-9.
40. Bessell T, Marriott J, Emmerton L, Nissen L. Improving Australians' access to prescription medicines: development of pharmacy practice models. Canberra: The Pharmacy Guild of Australia; 2005.
41. Child D, Hirsch C, Berry M. Health care professionals' views on hospital pharmacist prescribing in the United Kingdom. Int J Pharm Prac 1998; 6: 159-69.
42. Desikan R, Holiday-Goodman M, Siganga WW, Lively BT. Prescribing authority: an examination of Ohio pharmacists' opinions. Am Pharm 1995; NS35: 19-23.
43. Streit RJ. A program expanding the pharmacist's role. J Am Pharm Assoc 1973; NS13: 482-5.
44. Taryle DA, Anderson PO. Pharmacist management of ambulatory patients using formalized standards of care. Am J Hosp Pharm 1974; 31: 254-57.
45. Brennan C. Pharmacist prescribing: Harbourview medical center. Pharm Pract Manage Q 1995; 15: 24-30.
46. Koch KE. Trends in collaborative drug therapy management. Drug Benefit Trends 2000; 12: 45-54.
47. Reichert SL. Developing a protocol for collaborative drug therapy management. Am J Health Syst Pharm 1999; 56: 1715-7.
48. Child D, Cantrill JA. Hospital doctors' perceived barriers to pharmacist prescribing. Int J Pharm Prac 1999; 7: 230-7.
49. Segal R, Grines LL. Prescribing authority for pharmacists as viewed by organized pharmacy, organized medicine, and the pharmaceutical industry. Drug Intell Clin Pharm 1988; 22: 241-6.
50. St Jean Wittenburg A. Obtaining prescribing authority for pharmacists: lessons learned. Am J Health Syst Pharm 1995; 52: 1616, 1620, 1623-4, 1626, 1629.
51. Anonymous. No obstacle to pharmacists prescribing. Pharm J 2002; 269: 450.
52. Bellingham C. Space, time and team working: issues for pharmacists who wish to prescribe. Pharm J 2002; 268: 562-3.
53. Boatwright DE. Legal aspects of expanded prescribing authority for pharmacists. Am J Health Syst Pharm 1998; 55: 585-94.
54. Roberts A, Benrimoj SI, Chen T, Williams K, Asiani P. An investigation into business and professional facilitators for change for the pharmacy profession in light of the third guild/government agreement. Canberra: The Pharmacy Guild of Australia; 2003.
55. Health Care Intelligence Pty Ltd. A study of the demand and supply of pharmacists, 2000-2010. Canberra: Health Care Intelligence Pty Ltd; 2003.